BMEA
Price
$1.80
Change
-$0.01 (-0.55%)
Updated
Jun 30, 04:59 PM (EDT)
Capitalization
106.06M
35 days until earnings call
COGT
Price
$7.18
Change
+$0.08 (+1.13%)
Updated
Jun 30, 04:59 PM (EDT)
Capitalization
808.95M
43 days until earnings call
Interact to see
Advertisement

BMEA vs COGT

Header iconBMEA vs COGT Comparison
Open Charts BMEA vs COGTBanner chart's image
Biomea Fusion
Price$1.80
Change-$0.01 (-0.55%)
Volume$10.12K
Capitalization106.06M
Cogent Biosciences
Price$7.18
Change+$0.08 (+1.13%)
Volume$71.96K
Capitalization808.95M
BMEA vs COGT Comparison Chart in %
Loading...
BMEA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
COGT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BMEA vs. COGT commentary
Jul 01, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BMEA is a Buy and COGT is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 01, 2025
Stock price -- (BMEA: $1.81 vs. COGT: $7.10)
Brand notoriety: BMEA and COGT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BMEA: 160% vs. COGT: 309%
Market capitalization -- BMEA: $106.06M vs. COGT: $808.95M
BMEA [@Biotechnology] is valued at $106.06M. COGT’s [@Biotechnology] market capitalization is $808.95M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BMEA’s FA Score shows that 0 FA rating(s) are green whileCOGT’s FA Score has 0 green FA rating(s).

  • BMEA’s FA Score: 0 green, 5 red.
  • COGT’s FA Score: 0 green, 5 red.
According to our system of comparison, BMEA is a better buy in the long-term than COGT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BMEA’s TA Score shows that 5 TA indicator(s) are bullish while COGT’s TA Score has 4 bullish TA indicator(s).

  • BMEA’s TA Score: 5 bullish, 5 bearish.
  • COGT’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, BMEA is a better buy in the short-term than COGT.

Price Growth

BMEA (@Biotechnology) experienced а 0.00% price change this week, while COGT (@Biotechnology) price change was -1.80% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.68%. For the same industry, the average monthly price growth was +32.84%, and the average quarterly price growth was +6.72%.

Reported Earning Dates

BMEA is expected to report earnings on Aug 04, 2025.

COGT is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+3.68% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
COGT($809M) has a higher market cap than BMEA($106M). COGT YTD gains are higher at: -8.974 vs. BMEA (-53.351). BMEA has higher annual earnings (EBITDA): -130.93M vs. COGT (-284.04M). COGT has more cash in the bank: 246M vs. BMEA (35.9M). BMEA has less debt than COGT: BMEA (7.93M) vs COGT (17.1M). BMEA (0) and COGT (0) have equivalent revenues.
BMEACOGTBMEA / COGT
Capitalization106M809M13%
EBITDA-130.93M-284.04M46%
Gain YTD-53.351-8.974594%
P/E RatioN/AN/A-
Revenue00-
Total Cash35.9M246M15%
Total Debt7.93M17.1M46%
FUNDAMENTALS RATINGS
COGT: Fundamental Ratings
COGT
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
82
Overvalued
PROFIT vs RISK RATING
1..100
69
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
41
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BMEACOGT
RSI
ODDS (%)
Bearish Trend 4 days ago
81%
Bearish Trend 4 days ago
85%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
77%
Bearish Trend 4 days ago
83%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
82%
MACD
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 4 days ago
84%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
84%
Bearish Trend 4 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
84%
Bullish Trend 4 days ago
83%
Advances
ODDS (%)
Bullish Trend 6 days ago
83%
Bullish Trend 14 days ago
83%
Declines
ODDS (%)
Bearish Trend 8 days ago
90%
Bearish Trend 6 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
78%
Bearish Trend 4 days ago
89%
Aroon
ODDS (%)
Bullish Trend 4 days ago
87%
Bullish Trend 4 days ago
77%
View a ticker or compare two or three
Interact to see
Advertisement
BMEA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
COGT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HIIDX14.180.09
+0.64%
Harbor Diversified Intl All Cp Inv
MADFX34.830.12
+0.35%
Matrix Advisors Dividend
TQCRX19.060.06
+0.32%
Touchstone Dividend Equity R6
DOXBX107.510.32
+0.30%
Dodge & Cox Balanced X
HNVIX33.32N/A
N/A
Heartland Value Plus Institutional

BMEA and

Correlation & Price change

A.I.dvisor indicates that over the last year, BMEA has been loosely correlated with CCCC. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if BMEA jumps, then CCCC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BMEA
1D Price
Change %
BMEA100%
-9.05%
CCCC - BMEA
44%
Loosely correlated
-7.89%
TCRX - BMEA
39%
Loosely correlated
-5.41%
CAI - BMEA
38%
Loosely correlated
+0.22%
IDYA - BMEA
38%
Loosely correlated
-4.13%
COGT - BMEA
37%
Loosely correlated
-3.14%
More